Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 520 Breast Neoplasms 457 Lung Neoplasms 254 Prostatic Neoplasms 234 Colorectal Neoplasms 216 Carcinoma, Non-Small-Cell Lung 186 Pancreatic Neoplasms 154 Carcinoma, Hepatocellular 137 Stomach Neoplasms 134 Ovarian Neoplasms 116 Multiple Myeloma 98 Head and Neck Neoplasms 94 Melanoma 93 Esophageal Neoplasms 90 Disease 87 Urinary Bladder Neoplasms 86 Uterine Cervical Neoplasms 78 Lymphoma 78 Brain Neoplasms 76 Hematologic Neoplasms 75 Liver Neoplasms 74 Endometrial Neoplasms 71 Neoplasm Metastasis 66 Leukemia, Myeloid, Acute 66 Rectal Neoplasms 61 Colonic Neoplasms 61 Precursor Cell Lymphoblastic Leukemia-Lymphoma 56 Sarcoma 53 Glioma 53 Thyroid Neoplasms 52

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Observational × Hormone Receptor Positive Breast Cancer × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡